CCChristelle Creac'H

Christelle Creac'H

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christelle Creac'H has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Potentiels évoqués nociceptifs par électrode concentrique : effet du CIDN

    by Emmanuel Lambert, Christelle Créac’H, Roland Peyron, Philippe Convers

  • Potentiels évoqués pneumatiques : effets du CIDN et de l’habituation

    by Etienne Pigeon, Philippe Convers, Christelle Créac’h, Roland Peyron

  • Thalamic pain: anatomical and physiological indices of prediction

    by Nuutti Vartiainen, Caroline Perchet, Michel Magnin, Christelle Creac’h, Philippe Convers, Norbert Nighoghossian, François Mauguière, Roland Peyron, Luis Garcia-Larrea

    Thalamic pain is a severe and treatment-resistant type of central pain that may develop after thalamic stroke. Lesions within the ventrocaudal regions of the thalamus carry the highest risk to develop pain, but its emergence in individual patients remains impossible to predict. Because damage to the spino-thalamo-cortical system is a crucial factor in the development of central pain, in this study we combined detailed anatomical atlas-based mapping of thalamic lesions and assessment of spinothalamic integrity using quantitative sensory analysis and laser-evoked potentials in 42 thalamic stroke patients, of whom 31 had developed thalamic pain. More than 97% of lesions involved an area between 2 and 7 mm above the anterior–posterior commissural plane. Although most thalamic lesions affected several nuclei, patients with central pain showed maximal lesion convergence on the anterior pulvinar nucleus (a major spinothalamic target) while the convergence area lay within the ventral posterior lateral nucleus in pain-free patients. Both involvement of the anterior pulvinar nucleus and spinothalamic dysfunction (nociceptive thresholds, laser-evoked potentials) were significantly associated with the development of thalamic pain, whereas involvement of ventral posterior lateral nucleus and lemniscal dysfunction (position sense, graphaesthesia, pallaesthesia, stereognosis, standard somatosensory potentials) were similarly distributed in patients with or without pain. A logistic regression model combining spinothalamic dysfunction and anterior pulvinar nucleus involvement as regressors had 93% sensitivity and 87% positive predictive value for thalamic pain. Lesion of spinothalamic afferents to the posterior thalamus appears therefore determinant to the development of central pain after thalamic stroke. Sorting out of patients at different risks of developing thalamic pain may be achievable at the individual level by combining lesion localization and functional investigation of the spinothalamic system. As the methods proposed here do not need complex manipulations, they can be added to routine patients’ work up, and the results replicated by other investigators in the field.


  • Robot‐guided neuronavigated rTMS as an alternative therapy for central (neuropathic) pain: Clinical experience and long‐term follow‐up

    by B. Pommier, C. Créac'H, V. Beauvieux, C. Nuti, F. Vassal, R. Peyron

    Background: Repetitive transcranial magnetic stimulation (rTMS) appears as a useful tool to alleviate neuropathic pain but only few data are available for the long‐term benefit of this treatment.Methods: Here we report the effects of rTMS sessions, considered as a possible therapy for pain relief after a failure of different medications in patients with central (neuropathic) pain. We review here the prospectively collected data of the first forty patients treated as follow: 20 Hz stimulation delivered over the contralateral primary motor cortex (M1), each 3–4 weeks.Results: A total of 440 rTMS sessions was collected (mean sessions number: 11, range: 1–37, follow‐up 312 days on average, maximum 2.8 years). After four sessions, nine patients (22.5%) discontinued rTMS because of a lack of efficiency (R = 0.649. p = 5.6*10−6). Both intensity and duration of pain relief were significantly better for patients with persistent laser evoked potentials (LEPs, p = 0.049 and 0.0018). We did not observe any adverse‐effects.Conclusion: These results suggest that repeated sessions of 20 Hz rTMS over M1 are interesting in clinical practice for the treatment of selected patients with central pain. Both the cumulative effects across the first sessions and the long duration of pain‐relief should impact further randomized trials that are warranted to conclude formally on rTMS efficiency in central pain.


  • Effects of aging on laser evoked potentials

    by Christelle Creac'H, Alexandre Bertholon, Philippe Convers, Luis Garcia‐Larrea, Roland Peyron

    Introduction: Aging has been reported to reduce the amplitude of laser evoked potentials. However, it is unknown whether this effect depends on the length of the sensory fibers. This is an important issue, because most painful neuropathies are length‐dependent. Methods: We conducted a study of 40 healthy subjects, half of whom were older than age 50 years. Nociceptive stimuli were delivered to the feet and thighs using a CO2 laser stimulator. Results: Detection and pain perception thresholds did not correlate with age. Latencies of N1, N2, and P2 correlated positively with age on the feet but not on the thighs, whereas the amplitude of N2‐P2 decreased with age for both areas. Conclusions: The effects of aging on latencies may reflect a distal loss of peripheral inputs and a length‐dependent de‐synchronization of the ascending nociceptive volley. Additional changes in peripheral and central processes may explain the diffuse decrease of N2‐P2 amplitudes observed with aging. Muscle Nerve 51:736–742, 2015


  • Neuro-imagerie fonctionnelle et migraine

    by G. Demarquay, C. Creac’h

    Les méthodes d’imagerie neurofonctionnelle ont permis de montrer que la migraine n’était pas uniquement une pathologie trigéminovasculaire d’origine périphérique comme on le pensait initialement, mais qu’elle impliquait des structures corticales et sous-corticales. Ces études ont ainsi montré l’implication des noyaux du tronc cérébral au cours des crises et conforté l’hypothèse d’une possible origine centrale de la migraine. Elles ont également confirmé indirectement l’hypothèse d’une dépression corticale envahissante au cours de l’aura et précisé les différents mécanismes corticaux impliqués dans les signes associés à la migraine comme la photophobie, l’osmophobie et l’allodynie. Le développement des études d’imagerie sur les neurorécepteurs pourrait constituer dans les prochaines années une étape fondamentale à la compréhension du rôle de différents neuromédiateurs impliqués dans la migraine. Neurofunctional imaging methods have made it possible to show that migraine is not uniquely a peripheral trigeminovascular condition, as was originally thought, but that cortical and sub-cortical structures are also involved. These studies have also shown the involvement of the brainstem nuclei during attacks and strengthened the hypothesis of a possible central origin for migraine. The studies also indirectly confirm the hypothesis of spreading cortical depression during aura and the various cortical mechanisms involved in the signs associated with migraine, such as photophobia, osmophobia and allodynia. Over the next few years, the development of imaging studies of neuroreceptors would be a fundamental step in the understanding of the role of the different neuromediators involved in migraine.

  • Olfactory hallucinations in primary headache disorders: Case series and literature review. A comment

    by Geneviève Demarquay, Christelle Créac’h, Roland Peyron